Finch Therapeutics Group, Inc. Quarterly Depreciation in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Finch Therapeutics Group, Inc. quarterly Depreciation history and growth rate from Q1 2020 to Q1 2023.
  • Finch Therapeutics Group, Inc. Depreciation for the quarter ending March 31, 2023 was $1.4M, a 7.69% increase year-over-year.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $1.4M +$100K +7.69% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $1.3M +$900K +225% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $400K +$200K +100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $200K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.